肺移植中的阿齐思罗米:重新审视其从预防到治疗的双重作用
Heng Huang1, Toyofumi Fengshi Chen-Yoshikawa1
1Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Aichi, Japan.
ERJ open research
|December 24, 2025
概括
阿齐思罗米显示出预防和治疗慢性肺异位移植功能障碍 (CLAD) 的潜力. 需要进一步的研究才能充分理解它在治疗这种疾病中的双重作用.
科学领域:
- 肺病学和移植医学 肺病学和移植医学
背景情况:
- 慢性肺异位移植功能障碍 (CLAD) 是肺移植后的一种严重并发症.
- 目前对CLAD的治疗选择有限,这凸显了对新型治疗策略的需求.
研究的目的:
- 调查阿齐思罗米在预防 (预防) 和治疗慢性肺异位移植功能障碍 (CLAD) 方面的双重作用.
- 强调需要对阿齐思罗米在治疗CLAD中的有效性进行全面研究.
主要方法:
- 这项研究突出了现有的关于阿齐思罗米影响的证据.
- 建议进行进一步的临床调查和试验,以验证发现.
主要成果:
- 在CLAD管理的初步研究中,阿齐思罗米已经显示出有前途的结果.
- 有证据表明,阿齐思罗米可能具有预防性和治疗性益处.
结论:
- 亚齐思罗米需要进一步全面调查其在CLAD中的潜在双重应用.
- 这些发现支持在不断变化的肺移植护理领域继续进行研究.
相关概念视频
Pulmonary Tuberculosis I
801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
Pulmonary Tuberculosis V
520
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520
Transmission-based Precautions II: Airborne and Protective Environment
1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Myocarditis III: Medical Management
155
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
155
Cystic Fibrosis: Management
438
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
438


